Sarepta Therapeutics Ownership | Who Owns Sarepta Therapeutics?

Overview Forecast RevenueFinancials Chart Transcripts

Sarepta Therapeutics Ownership Summary

Sarepta Therapeutics is owned by 6.51% institutional investors, 4.41% insiders, and 89.08% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 11.73% of SRPT shares. American Funds Growth Fund of Amer A is the top mutual fund, with 3.25% of its assets in Sarepta Therapeutics shares.

SRPT Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Sarepta Therapeutics	6.51%	4.41%	89.08%
Sector	Healthcare Stocks	279.17%	10.51%	-189.68%
Industry	Biotech Stocks	63.95%	10.67%	25.38%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock funding, inc. /de	11.19M	11.73%	$1.36B
Blackrock	10.32M	10.98%	$1.63B
Vanguard group	9.09M	9.52%	$1.10B
Capital investors	8.70M	9.12%	$1.06B
Janus henderson group	4.33M	4.54%	$526.20M
State street	4.14M	4.41%	$654.40M
Farallon capital management	2.87M	3.00%	$348.37M
Morgan stanley	2.62M	2.79%	$414.49M
Avoro capital advisors	2.67M	2.75%	$170.71M
Bank of new york mellon	2.15M	2.25%	$260.87M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Boxer capital	650.00K	5.41%	$102.70M
Casdin capital	900.78K	4.70%	$57.49M
Ecor1 capital	770.00K	3.54%	$93.62M
Camber capital management lp	1.00M	2.81%	$121.59M
Ghost tree capital	55.00K	2.72%	$8.69M
Avoro capital advisors	2.67M	2.66%	$170.71M
Palo alto investors lp	210.26K	2.56%	$13.42M
Sphera funds management	98.92K	2.17%	$12.03M
Deep track capital, lp	899.73K	1.86%	$57.42M
Farallon capital management	2.87M	1.77%	$348.37M

Top Buyers

Holder	Shares	% Assets	Change
Blackrock	10.32M	0.04%	4.36M
Capital investors	8.70M	0.20%	2.44M
State street	4.14M	0.03%	2.02M
Morgan stanley	2.62M	0.03%	1.73M
Ubs group	1.48M	0.03%	1.12M

Top Sellers

Holder	Shares	% Assets	Change
Orbimed advisors	-	-	-963.40K
Paradigm biocapital advisors lp	-	-	-947.57K
Wellington management group llp	2.07M	0.05%	-657.84K
Fmr	692.87K	0.01%	-542.88K
Perceptive advisors	-	-	-525.68K

New Positions

Holder	Shares	% Assets	Change	Value
Norges bank	1.04M	0.02%	1.04M	$126.32M
Deep track capital, lp	899.73K	1.86%	899.73K	$57.42M
Raymond james financial	396.82K	0.02%	396.82K	$48.25M
Brandywine global investment management	185.98K	0.16%	185.98K	$22.61M
Swedbank ab	137.40K	0.02%	137.40K	$16.71M

Sold Out

Holder	Change
Financial gravity asset management	-1.00
Harbor investment advisory	-1.00
Tfc financial management	-1.00
Trust co of vermont	-2.00
Coppell advisory solutions	-2.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2025	23	-95.40%	6,342,126	-92.89%	6	0.07%	12	-95.02%	7	-95.39%
Dec 31, 2024	187	-62.75%	19,880,204	-77.21%	20	0.25%	88	-61.40%	54	-65.82%
Sep 30, 2024	498	-6.57%	87,082,917	-1.33%	91	1.04%	226	-23.65%	157	18.05%
Jun 30, 2024	528	18.39%	88,255,346	8.04%	93	1.24%	293	35.02%	132	4.76%
Mar 31, 2024	446	1.59%	81,685,557	0.50%	86	1.12%	217	7.43%	126	-11.89%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
American Funds Growth Fund of Amer A	3.15M	3.25%	-5.26K
Capital Group Growth Fnd of Amer Comp	3.15M	3.21%	-5.26K
iShares Core S&P Mid-Cap ETF	3.10M	3.16%	2.04K
Vanguard Total Stock Mkt Idx Inv	2.90M	2.96%	38.48K
Vanguard US Total Market Shares ETF	2.85M	2.94%	2.16K
American Funds AMCAP A	2.66M	2.74%	133.61K
Capital Group AMCAP Composite	2.66M	2.71%	133.61K
VA CollegeAmerica Amcap 529A	2.52M	2.64%	425.56K
Vanguard Small Cap Index	2.28M	2.32%	16.14K
Vanguard Health Care Inv	1.80M	1.84%	502.05K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Mar 12, 2025	Nicaise Claude	-	Sell	$248.20K
Dec 12, 2024	Wigzell Hans Lennart Rudolf	-	Sell	$1.31M
Dec 05, 2024	Boor Kathryn Jean	-	Sell	$205.40K
Aug 30, 2024	Estepan Ian Michael	Chief Financial Officer	Sell	$822.10K
Aug 16, 2024	Chambers Michael Andrew	-	Buy	$2.45M

Insider Transactions Trends

Date	Buy	Sell
2025 Q2	-	-
2025 Q1	-	1
2024 Q3	3	1
2024 Q2	-	14
2024 Q1	-	9

SRPT Ownership FAQ

Who Owns Sarepta Therapeutics?

Sarepta Therapeutics shareholders are primarily institutional investors at 6.51%, followed by 4.41% insiders and 89.08% retail investors. The average institutional ownership in Sarepta Therapeutics's industry, Biotech Stocks , is 63.95%, which Sarepta Therapeutics falls below.

Who owns the most shares of Sarepta Therapeutics?

Sarepta Therapeutics’s largest shareholders are Blackrock funding, inc. /de (11.19M shares, 11.73%), Blackrock (10.32M shares, 10.98%), and Vanguard group (9.09M shares, 9.52%). Together, they hold 32.24% of Sarepta Therapeutics’s total shares outstanding.

Does Blackrock own Sarepta Therapeutics?

Yes, BlackRock owns 10.98% of Sarepta Therapeutics, totaling 10.32M shares as of Jun 2024. This represents 0.04% of BlackRock's total assets, with a market value of 1.63B$. In the last quarter, BlackRock increased its holdings by 4.36M shares, a 73.22% change.

Who is Sarepta Therapeutics’s biggest shareholder by percentage of total assets invested?

Boxer capital is Sarepta Therapeutics’s biggest shareholder by percentage of total assets invested, with 5.41% of its assets in 650K Sarepta Therapeutics shares, valued at 102.7M$.

Who is the top mutual fund holder of Sarepta Therapeutics shares?

American Funds Growth Fund of Amer A is the top mutual fund holder of Sarepta Therapeutics shares, with 3.25% of its total shares outstanding invested in 3.15M Sarepta Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools